Hiroyuki Yanai

Hiroyuki Yanai

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
PDF file
AMAtsuji Matsuyama
Atsuji Matsuyama
ESEisuke Shiba
Eisuke Shiba
YUYoshihisa Umekita
Yoshihisa Umekita
KNKanae Nosaka
Kanae Nosaka
TKTakihiro Kamio
Takihiro Kamio
MHMasanori Hisaoka
Masanori Hisaoka
Undifferentiated sarcoma harboring the BCOR-CCNB3 fusion is characterized by its predilection to affect skeletons of adolescent males, cellular small round/spindle cell morphology, and CCNB3 immunoreactivity. We analyzed 11 cases of BCOR-CCNB3 sarcoma, 10 of which were identified in a reverse transcription-polymerase chain reaction–based screen of 85 patient samples recorded in our database as unclassified small round or spindle cell sarcomas. BCOR rearrangements were confirmed by fluorescence in situ hybridization in 8 tumors. All patients were males aged between 6 and 31 years. In addition to 5 tumors in soft tissue and 4 in the axial or appendicular skeletons, which are typical locations, a tumor was located in the paranasal sinus and another in the lung. Microscopically, the tumors comprised proliferating atypical spindle and/or small round cells with diverse morphologic features such as small concentric whorls, myxoid stroma, a hemangiopericytomatous appearance, and/or hyalinized collagen resembling a solitary fibrous tumor, and angiomatous or slit-like spaces containing extravasated erythrocytes. Tumor cells were immunoreactive to CCNB3 (9/11), BCOR (10/10), TLE1 (6/10), bcl-2 (9/11), CD99 (8/10), CD56 (8/10), c-kit (4/10), and cyclin D1 (10/10). In an immunohistochemical analysis of an additional 412 small round or spindle cell tumors, CCNB3 was detected in 6 (1.5%) and BCOR in 18 (4.4%). Our analysis highlights the varying clinicopathologic features of this tumor, which partially overlap with other small round or spindle cell tumors, including solitary fibrous tumor and vascular tumors. Because CCNB3 and BCOR immunohistochemistry lacks adequate sensitivity and specificity, a molecular genetic approach remains essential for diagnosis.

1 April 2013 in Laboratory Investigation
Verified
Journal Article
Closed access
YSYasuharu Sato
Yasuharu Sato
MTMai Takeuchi
Mai Takeuchi
KTKatsuyoshi Takata
Katsuyoshi Takata
KOKyotaro Ohno
Kyotaro Ohno
NINoriko Iwaki
Noriko Iwaki
TYTadashi Yoshino
Tadashi Yoshino

8 June 2010 in Pathology International
Verified
Journal Article
Closed access
PDF file
HYHiroyuki Yanai
Hiroyuki Yanai
YWYoji Wani
Yoji Wani
KNKenji Notohara
Kenji Notohara
STShin-Ichi Takada
Shin-Ichi Takada
TYTadashi Yoshino
Tadashi Yoshino

1 September 2019 in Advances in Anatomic Pathology
Verified
Journal Article
Open access
YHYuichiro Hatano
Yuichiro Hatano
KHKayoko Hatano
Kayoko Hatano
MTMaho Tamada
Maho Tamada
KMKen-Ichirou Morishige
Ken-Ichirou Morishige
HTHiroyuki Tomita
Hiroyuki Tomita
AHAkira Hara
Akira Hara
Although ovarian serous carcinoma is a well-studied human gynecologic malignancy, this high-grade tumor remains fatal. The main purpose of this review is to summarize the accumulated evidence on serous malignant tumors and to clarify the unresolved issues. We discuss the 8 dichotomies of serous carcinoma: high grade versus low grade, ovarian versus extraovarian primary, extrauterine versus uterine primary, sporadic versus hereditary, orthodox versus alternative histology, p53 overexpression versus complete absence of immunophenotype, TP53-mutated versus intact precursor, and therapy responsive versus refractory. In addition, we summarize the molecular classification of high-grade serous carcinoma. This review would lead readers to rapid and parallel developments in understanding high-grade serous carcinoma.

1 September 1998 in The American Journal of Pathology
Verified
Journal Article
Closed access
KTKiyoshi Takahashi
Kiyoshi Takahashi
KAKenji Asagoe
Kenji Asagoe
JZJin Zaishun
Jin Zaishun
HYHiroyuki Yanai
Hiroyuki Yanai
TYTadashi Yoshino
Tadashi Yoshino
TATadaatsu Akagi
Tadaatsu Akagi

1 January 2003 in Pathology - Research and Practice
Verified
Journal Article
Closed access
HYHiroyuki Yanai
Hiroyuki Yanai
HMHiroo Matsuura
Hiroo Matsuura
HSHiroshi Sonobe
Hiroshi Sonobe
SSShigehiro Shiozaki
Shigehiro Shiozaki
KKKenji Kawabata
Kenji Kawabata